Saltigo has signed a contract for another production campaign of the insect pheromone Pheron E7-E/Z9-12Ac with Provivi, which provides crop protection systems via pheromone technology. The two companies worked together to complete the technical transfer, optimisation and scale-up to tonne volumes at Saltigo’s site in Leverkusen.
Malaysian petrochemicals giant Petronas Chemical Group (PCG) has agreed to acquire Perstorp from its private equity owner, Financière Forêt. The €1.54 billion cash acquisition gives Perstorp an enterprise value of €2.3 billion. It should close in 2H 2022, subject to regulatory and shareholder approvals.
Circa and Valmet have agreed a long-term partnership to optimise Circa’s Furacell production process for biochemicals at scale through the ReSolute project and in future large-scale plants. Valmet, which has wide experience in fluidised bed boilers and biomass-to-energy systems, will be the main process technology and equipment supplier.
Distributor IMCD has formed a new business group called Industrial Solutions, which will absorb the previous Synthesis group and areas of the other industries it serves. This has been done in response to such global trends as growing demand for products in applications like high-temperature, electronics and batteries, and sustainability, notably in recycling and water treatment.
Oleochemicals firm Oleon has begun construction of a $50 million production facility in Baytown, Texas. Due to be put into service end of 2023, this will produce esters and provide blending services to support the firm’s growing oil and gas business, while bringing it closer to customers in the North America, according to CEO Moussa Naciri.
Bryan Moran, global skin care technical manager at Lubrizol Life Science Beauty, discusses how formulators can address a key trend in sun care
In the 1970s and 1980s, no lifeguard would hit the beach without a thick white coating of zinc oxide sunblock on their nose. It was effective but also unattractive and uncomfortable.
A little flexibility in approach will improve consistency and enable pharma partners to perform to their optimum level. Ahead of her presentation on ‘How to Build a ‘Framework for Managing Your Outsourcing Partner’ at CPhI North America, we spoke with Stephanie Gaulding, executive director of regulatory compliance at Pharmatech Associates
